Publications 2005
38.
Theodorescu D, Fliser D, Wittke S, Mischak H, Krebs R, Walden M, Eltze E, Bettendorf O, Wuelfing C, Semjonow Axel.
Pilot study of capillary electrophoresis coupled to mass Spectrometry as a tool to define potential prostate cancer biomarkers in urine
Tumor Biology 2005, 27(Suppl1): 48.
37.
Kolch W, Neususs C, Pelzing M, Mischak H
Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery
Mass Spectrom Rev. 2005, 24(6): 959-977
View
Abstract Request
Reprint
36.
Chalmers MJ, Mackay CL, Hendrickson CL, Wittke S, Walden M, Mischak H, Fliser D, Just I, Marshall AG
Combined top-down and bottom-up mass spectrometric approach to characterization of biomarkers for renal disease
Anal Chem. 2005, 77(22): 7163-7171
View
Abstract Request
Reprint
35.
Weissinger EM, Hertenstein B, Mischak H, Ganser A
Online coupling of capillary electrophoresis with mass spectrometry for the identification of biomarkers for clinical diagnosis
Expert Reviews In: Proteomics 2005, 2(5): 639-647
View
Abstract Request
Reprint
34.
Wittke S, Haubitz M, Walden M, Rohde F, Schwarz A, Mengel M, Mischak H, Haller H, Gwinner W
Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipients
Am J Transplant. 2005, 5(10): 2479-2488
View
Abstract Request
Reprint
33.
Meier M, Kaiser T, Herrmann A, Knueppel S, Hillmann M, Koester P, Danne T, Haller H, Fliser D, Mischak H
Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis
J Diabetes Complications. 2005, 19(4): 223-232
View
Abstract Request
Reprint
32.
Rossing K, Mischak H, Parving HH, Christensen PK, Walden M, Hillmann M, Kaiser T
Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns
Kidney Int. 2005, 68(1): 193-205
View
Abstract Request
Reprint
31.
Theodorescu D, Fliser D, Wittke S, Mischak H, Krebs R, Walden M, Ross M, Eltze E, Bettendorf O, Wulfing C, Semjonow A
Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine
Electrophoresis. 2005, 26(14): 2797-2808
View
Abstract Request
Reprint
30.
Gwinner W, Haubitz M, Walden M, Rohde F, Schwarz A, Mengel M, Mischak H, Haller H, Wittke S.
Detection of acute rejection in renal transplant recipients by proteomic analysis of urine samples with ESI-TOF mass spectrometry
American Journal of Transplantation 2005, 5(s11): 390.
29.
Fliser D, Wittke S, Mischak H
Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes
Electrophoresis. 2005, 26(14): 2708-2716
View
Abstract Request
Reprint
28.
Haubitz M, Wittke S, Weissinger EM, Walden M, Rupprecht HD, Floege J, Haller H, Mischak H
Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy
Kidney Int. 2005, 67(6): 2313-2320
View
Abstract Request
Reprint
27.
Weissinger EM, Walden M, Diedrich H, Kolb HJ, Zander A, Holler E, Ganser A, Mischak H, Hertenstein B.
Prospective evaluation of a GvHD-specific proteomics pattern
Bone Marrow Transplant. 2005, 35(Suppl2): S43-S44.
26.
Rogers S, Girolami M, Krebs R, Mischak H.
Disease classification from capillary electrophoresis: mass spectrometry
Pattern Recognition and Data Mining 2005, Editors: S. Singh et al. ICAPR 2005, LNCS 3686, pp. 183-191.
25.
Raedler TJ, Wittke S, Mischak H, Jahn H, Wiedemann K.
Disease-specific polypeptide-patterns in CSF in schizophrenia and Alzheimer disease
Schizophrenia Bulletin 2005, 31(2): 292.
24.
Mischak H, Haubitz M, Haller H, Ruprecht H, Floege J, Wittke S, Walden M, Rossing K, Fliser D.
Defining renal diseases based on proteome analysis
Nephrology (Carlton) 2005, 10( Suppl1): A343.
23.
Decramer S, Wittke S, Mischak H, Bouissou F, Bascands JL, Schanstra JP.
Use of proteomic patterns to predict the outcome of congenital unilateral ureteropelvic junction obstruction in newborns
Nephrology (Carlton) 2005, 10( Suppl1): A11.
22.
Haubitz M, Fliser D, Rupprecht H, Flöge J, Haller H, Rossing K, Walden M, Wittke S, Mischak H.
Defining renal diseases based on proteome analysis
Nephrol Dial Transplant. 2005, 20(Suppl5): v20
21.
Wittke S, Haubitz M, Walden M, Rohde F, Mengel ASM, Mischak H, Gwinner W.
Detection of acute rejection by proteomic analysis of urinary samples in renal transplant recipients
Nephrol Dial Transplant. 2005, 20(Suppl5): v158
20.
Kolch W, Mischak H, Pitt AR
The molecular make-up of a tumour: proteomics in cancer research
Clin Sci (Lond). 2005, 108(5): 369-383
View
Abstract Request
Reprint
19.
Wittke S, Mischak H, Walden M, Kolch W, Radler T, Wiedemann K
Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: towards new diagnostic and therapeutic approaches
Electrophoresis. 2005, 26(7-8): 1476-1487
View
Abstract Request
Reprint
18.
Hillman M, Mischak H
CE-MS as a Tool for Renal Disease Analysis and Biomarker Discovery Pace Setter
The worldwide newsletter for capillary electrophoresis (Beckman Coulter) 2005, 9(2): 1-5
Request
Reprint
17.
Walden M, Mischak H
Proteomanalyse mittels Kapillarelektrophorese-gekoppelter Massenspektrometrie - ein neues Routineverfahren in der klinischen Diagnostik?
Klinische Chemie Mitteilungen 2005, 36(5): 87-101
Request
Reprint